Showing results (41-50 of 301) with videos related to
Sort By:
Pageof 31
Advanced Drug Delivery Reviews|May 30, 2008
Use of antibodies and immunoconjugates for the therapy of more accessible cancersRobert M Sharkey, David M GoldenbergTherapeutic Delivery|July 24, 2012
Recent progress in cancer therapy with radiolabeled monoclonal antibodiesDavid M Goldenberg, Robert M SharkeyThescientificworldjournal|October 19, 2010
New antibody conjugates in cancer therapySerengulam V Govindan, David M GoldenbergHospital Practice (1995)|October 5, 2010
Radioactive antibodies: a historical review of selective targeting and treatment of cancerDavid M Goldenberg, Robert M SharkeyCA: a Cancer Journal for Clinicians|July 28, 2006
Targeted therapy of cancer: new prospects for antibodies and immunoconjugatesRobert M Sharkey, David M GoldenbergCancer Investigation|February 10, 2006
Advances in radioimmunotherapy in the age of molecular engineering and pretargetingRobert M Sharkey, David M GoldenbergEuropean Journal of Nuclear Medicine and Molecular Imaging|February 13, 2008
Therapy of human carcinoma xenografts with antibodies to EGFr and HER-2 conjugated to radionuclides emitting low-energy electronsM Jules Mattes, David M GoldenbergCurrent Opinion in Investigational Drugs (London, England : 2000)|November 28, 2008
Novel radioimmunopharmaceuticals for cancer imaging and therapyRobert M Sharkey, David M GoldenbergExpert Opinion on Biological Therapy|April 18, 2020
Sacituzumab govitecan, a novel, third-generation, antibody-drug conjugate (ADC) for cancer therapyDavid M Goldenberg, Robert M SharkeyPageof 31